Lexicon Pharmaceuticals
LXRX
LXRX
118 hedge funds and large institutions have $1.46B invested in Lexicon Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 36 increasing their positions, 35 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
3% less call options, than puts
Call options by funds: $10.9M | Put options by funds: $11.3M
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
118
Holding in Top 10
2
Calls
$10.9M
Puts
$11.3M
Top Buyers
| 1 | +$14.8M | |
| 2 | +$10.1M | |
| 3 | +$8.62M | |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$8.43M |
| 5 |
Millennium Management
New York
|
+$7.07M |
Top Sellers
| 1 | -$14.4M | |
| 2 | -$6.45M | |
| 3 | -$5.6M | |
| 4 |
MCM
Masters Capital Management
Atlanta,
Georgia
|
-$5.37M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$4.3M |